Insiders Amarantus BioScience Holdings, Inc.

Equities

AMBS

US02300U2050

Delayed OTC Markets Other stock markets 15:51:04 2024-05-15 EDT			5-day change	1st Jan Change
0.0001 ^USD	0.00%		0.00%	-80.00%

2022	Sector Update: Financial Stocks Still Adding to Wednesday Declines	MT
2020	Todos Medical Ltd. (OTCPK:TOMD.F) completed the acquisition of remaining 80.01% stake in Breakthrough Diagnostics Inc. from Amarantus BioScience Holdings, Inc.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amarantus Bioscience Holdings, Inc. Names Michael T. Ropacki as Chief Medical Advisor to Alzheimer's Blood Diagnostic LymPro Test Program	18-04-16	CI
Amarantus BioScience Holdings, Inc. Announces Executive Changes	18-04-05	CI
Amarantus Bioscience Holdings, Inc Announces Resignation of Robert H. Trapp and Ronald Wei Resigned as Members of the Board of Directors	17-05-09	CI
Amarantus BioScience Holdings, Inc. Names Four New Appointees to Board of Directors and Interim-CFO	17-02-27	CI
Amarantus Announces Demise of Dr. Joseph Rubinfeld, Independent Director	17-02-10	CI
Amarantus Bioscience Holdings, Inc Announces Resignation of Robert Farrell as Chief Financial Officer	16-07-08	CI
Amarantus Bioscience Holdings, Inc Appoints Ravi Kiron as Sr. Vice President of Business Development	16-06-03	CI
Amarantus BioScience Holdings, Inc. Appoints Brian E. Harvey to its Strategic Advisory Board	16-03-04	CI
Amarantus Bioscience Holdings, Inc Announces Resignation of David Lowe as a Member of the Board of Directors	15-10-28	CI
Amarantus Bioscience Holdings, Inc Appoints Curtis Scribner as Sr. Vice President of Regulatory Affairs	15-10-26	CI
Amarantus Bioscience Holdings, Inc Announces Resignation of Iain G. Ross as Member of the Board of Directors	15-08-06	CI
Amarantus Bioscience Holdings, Inc will Change its Name to Amarantus Bioscience, Inc	15-06-10	CI
Amarantus BioScience Holdings Establishes Alzheimer's Disease Diagnostics Scientific Advisory Board	15-01-22	CI
Amarantus Bioscience Holdings, Inc. Appoints Elise Brownell as Senior Vice President of Operations and Project Management	14-12-11	CI
Amarantus Appoints Joseph Rubinfeld to its Board of Directors	14-12-08	CI
Amarantus Bioscience Holdings, Inc Appoints Iain Ross to Board of Directors	14-08-29	CI
Amarantus Bioscience Holdings, Inc Appoints Donald D. Huffman to the Board of Directors to Chair the Newly-Formed Audit Committee	14-07-28	CI
Amarantus Bioscience Holdings Establishes Office in Geneva, Switzerland; Appoints Mark Wakefield as Head of Clinical Development Across Amarantus' Diagnostic and Therapeutic Divisions	14-05-06	CI
Amarantus Bioscience Holdings, Inc. Appoints Dr. Charlotte Keywood Chief Medical Officer of its Therapeutics Division	14-04-08	CI
Amarantus Appoints Robert Farrell as Chief Financial Officer	14-04-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Amarantus BioScience Holdings, Inc.

Equities

AMBS

US02300U2050

Insiders

Filters